Page last updated: 2024-10-29

iopromide and Nephrogenic Systemic Fibrosis

iopromide has been researched along with Nephrogenic Systemic Fibrosis in 2 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pietsch, H1
Jost, G1
Frenzel, T1
Raschke, M1
Walter, J1
Schirmer, H1
Hütter, J1
Sieber, MA1
Kim, IY1
Lee, SB1
Lee, DW1
Song, SH1
Seong, EY1
Kwak, IS1

Other Studies

2 other studies available for iopromide and Nephrogenic Systemic Fibrosis

ArticleYear
Efficacy and safety of lanthanoids as X-ray contrast agents.
    European journal of radiology, 2011, Volume: 80, Issue:2

    Topics: Animals; Biopsy; Blood Chemical Analysis; Chromatography, High Pressure Liquid; Contrast Media; Cyto

2011
Long-term effect of radiocontrast-enhanced computed tomography on the renal function of chronic kidney disease patients.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:5

    Topics: Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Iohexol; Kidney; Kidney Failure, C

2012